On July 9, the Federal Trade Commission (FTC) released a scathing interim staff report based on their ongoing investigation of Pharmacy Benefit Managers (PBM). The report notes that six of the largest PBMs across the country handle nearly 95% of the prescriptions filled in the U.S. Intel indicates that the Reports indicate that the FTC is gearing up to file lawsuits against healthcare companies acting as PBMs. The PBMs are being accused of inflating medication costs.
